Biotech Blog http://www.biotechblog.com Commercial, legal, political, and scientific trends in biotechnology Sun, 05 Feb 2012 10:20:44 +0000 en hourly 1 http://wordpress.org/?v=3.3 38.919211-77.037777BiotechBloghttp://feedburner.google.com Oryzon Nominates Bispecific LSD1/MAOB Inhibitor as Drug Candidate to… http://feedproxy.google.com/~r/BiotechBlog/~3/i0waHYwDzg8/ http://www.biotechblog.com/2012/02/05/oryzon-nominates-bispecific-lsd1maob-inhibitor-as-drug-candidate-to/#comments Sun, 05 Feb 2012 10:20:44 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9165166.htm ORYZON announced today that it is entering preclinical development with its first drug candidate, a first-in-class bispecific inhibitor for the treatment of Huntington disease (HD). These inhibitors...(PRWeb February 05, 2012)Read the full story at ... <p><a href="http://feedads.g.doubleclick.net/~a/Sx9BZ1MxCOuXhhfFQAEzyIqyw6k/0/da"><img src="http://feedads.g.doubleclick.net/~a/Sx9BZ1MxCOuXhhfFQAEzyIqyw6k/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/Sx9BZ1MxCOuXhhfFQAEzyIqyw6k/1/da"><img src="http://feedads.g.doubleclick.net/~a/Sx9BZ1MxCOuXhhfFQAEzyIqyw6k/1/di" border="0" ismap="true"></img></a></p><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=i0waHYwDzg8:7gIPNIQHaeo:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=i0waHYwDzg8:7gIPNIQHaeo:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=i0waHYwDzg8:7gIPNIQHaeo:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?i=i0waHYwDzg8:7gIPNIQHaeo:gIN9vFwOqvQ" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/BiotechBlog/~4/i0waHYwDzg8" height="1" width="1"/> http://www.biotechblog.com/2012/02/05/oryzon-nominates-bispecific-lsd1maob-inhibitor-as-drug-candidate-to/feed/ 0 http://www.biotechblog.com/2012/02/05/oryzon-nominates-bispecific-lsd1maob-inhibitor-as-drug-candidate-to/http://ww1.prweb.com/prfiles/2011/09/27/9165166/tN_71649_Oryzon general SMALL 3.jpg Drug Patent Expirations for Feb 5 2012 http://feedproxy.google.com/~r/BiotechBlog/~3/PAWXfJbtYwk/ http://www.biotechblog.com/2012/02/05/drug-patent-expirations-for-feb-5-2012/#comments Sun, 05 Feb 2012 05:38:11 +0000 DrugPatentWatch.com Drug Patent Expirations http://www.biotechblog.com/?guid=5b84839a05d7acdac4ff9f92f113d4a6 If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations <table border="0" align="center"><TR><TD><a target="_new" href="http://commercialbiotechnology.com/"><img border="0" src="http://commercialbiotechnology.com/img/journal-of-commercial-biotechnology_728x90.gif" alt="Journal of Commercial Biotechnology"></a><!--/td&#62;--></tr><TR><TD align="right--"><BR><a href="http://www.drugpatentwatch.com/newsletter/ad.php"><B>ADVERTISE HERE</B></a>&#160;</td></tr></table></p><P align="center"><i>This newsletter is a free service of <a href="http://www.drugpatentwatch.com/amember/go.php?r=132&#38;i=l0">DrugPatentWatch</a></i><br /><B>DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents</B><BR /><table border="0" width="560" align="center"><TR><TD><div><b><b></b><b></b><b></b><b></b></b><div><h1>Simple flat-rate database subscription plans</h1><table><col><col><col><col><tr><td></td><td><a href="http://www.drugpatentwatch.com/ultimate">Ultimate Plan</a></td><td><a href="http://www.drugpatentwatch.com/premium">Premium Plan</a></td><td><a href="http://www.drugpatentwatch.com/basic">Basic Plan</a></td></tr><tr><td>One year</td><td>$1,895 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=1"><img src='http://www.DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><td>$1,695 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=3"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><td>$975 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=5"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></TD></a></tr><tr><td>One month</td><td>$475 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=2"><img src='http://www.DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><td>$375 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=4"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><TD>$275 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=6"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></td></a></tr><tr><td>48 hours</td><td></td><td>$95 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=37"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><TD>$75 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=36"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></td></a></tr><TR><TD colspan="4"><a href="http://www.drugpatentwatch.com/comparison.php">Plan comparison</a>&#160;&#160;&#160;&#160;<a href="http://www.drugpatentwatch.com/index.php?tourId=Tour&#38;skinId=safari">Site tour</a>&#160;&#160;&#160;&#160;<a href="http://www.drugpatentwatch.com/contact.php">Contact</a></td></tr></table></div><b><b></b><b></b><b></b><b></b></b></div><BR /></tr></tr></table><table border="0" width="710" align="center"><TR><TD><div> <b> <b></b> <b></b> <b></b> <b></b></b><div><h1>Drug Patent Expirations for Feb 5 2012</h1><table width='100%' border="0"><thead><tr><th>Tradename</th><th>Applicant</th><th>Generic Name</th><th>Patent Number</th><th> Patent Expiration</th></tr></thead><tbody><tr><td>GANIRELIX ACETATE INJECTION</td><td>Organon Usa Inc</td><td>ganirelix acetate</td><td>4,801,577</td><td>Feb 5, 2012</td></tr><tr><td>VISUDYNE</td><td>Qlt</td><td>verteporfin</td><td>6,074,666</td><td>Feb 5, 2012</td></tr><TR><TD colspan="10"><p>*Drugs may be covered by multiple patents or regulatory protections. See the <a href="http://www.drugpatentwatch.com/amember/go.php?r=132&#38;i=l0">DrugPatentWatch</a> database for complete details.</p></TD></tr></tbody></table></div> <b> <b></b> <b></b><b></b> <b></b></b></div><div align="center"><hr /><div><B>The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the <a href="http://www.drugpatentwatch.com/amember/go.php?r=132&#38;i=l0">DrugPatentWatch</a> database for complete details</b><BR><BR><B>DISCLAIMER:</B><BR />Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.<BR /><i>All trademarks and applicant names are the property of their respective owners or licensors.</i></div></div><div> <a href="http://feeds.feedburner.com/~f/Drugpatentwatch?a=k0IwB1UJ"><img src="http://feeds.feedburner.com/~f/Drugpatentwatch?d=41" border="0"></img></a> <a href="http://feeds.feedburner.com/~f/Drugpatentwatch?a=wqCu3CQS"><img src="http://feeds.feedburner.com/~f/Drugpatentwatch?i=wqCu3CQS" border="0"></img></a> <a href="http://feeds.feedburner.com/~f/Drugpatentwatch?a=QDyqwQpa"><img src="http://feeds.feedburner.com/~f/Drugpatentwatch?d=50" border="0"></img></a> </div> <p><a href="http://feedads.g.doubleclick.net/~a/04wh52oFvMdZQp6fozKsmfc8DbA/0/da"><img src="http://feedads.g.doubleclick.net/~a/04wh52oFvMdZQp6fozKsmfc8DbA/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/04wh52oFvMdZQp6fozKsmfc8DbA/1/da"><img src="http://feedads.g.doubleclick.net/~a/04wh52oFvMdZQp6fozKsmfc8DbA/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/BiotechBlog/~4/PAWXfJbtYwk" height="1" width="1"/> http://www.biotechblog.com/2012/02/05/drug-patent-expirations-for-feb-5-2012/feed/ 0 http://www.biotechblog.com/2012/02/05/drug-patent-expirations-for-feb-5-2012/ Neuroscientists Join Max Planck Florida Institute as Leaders of Two… http://feedproxy.google.com/~r/BiotechBlog/~3/eKJfeLMu3tc/ http://www.biotechblog.com/2012/02/04/neuroscientists-join-max-planck-florida-institute-as-leaders-of-two/#comments Sat, 04 Feb 2012 09:29:01 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9162575.htm Neuroscientists Hyungbae Kwon, PhD and Hiroki Taniguchi, PhD will join Max Planck Florida Institute as research group leaders. MPFI will now have eight research groups, each dedicated to...(PRWeb February 04, 2012)Read the full story at http://www.... <p><a href="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/0/da"><img src="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/1/da"><img src="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/1/di" border="0" ismap="true"></img></a></p><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=eKJfeLMu3tc:IEzJieJ7hUE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=eKJfeLMu3tc:IEzJieJ7hUE:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=eKJfeLMu3tc:IEzJieJ7hUE:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?i=eKJfeLMu3tc:IEzJieJ7hUE:gIN9vFwOqvQ" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/BiotechBlog/~4/eKJfeLMu3tc" height="1" width="1"/> http://www.biotechblog.com/2012/02/04/neuroscientists-join-max-planck-florida-institute-as-leaders-of-two/feed/ 0 http://www.biotechblog.com/2012/02/04/neuroscientists-join-max-planck-florida-institute-as-leaders-of-two/ Neuroscientists Join Max Planck Florida Institute as Leaders of Two… http://feedproxy.google.com/~r/BiotechBlog/~3/eKJfeLMu3tc/ http://www.biotechblog.com/2012/02/04/neuroscientists-join-max-planck-florida-institute-as-leaders-of-two/#comments Sat, 04 Feb 2012 09:29:01 +0000 Science: Biotechnology http://www.prweb.com/releases/2012/2/prweb9162575.htm Neuroscientists Hyungbae Kwon, PhD and Hiroki Taniguchi, PhD will join Max Planck Florida Institute as research group leaders. MPFI will now have eight research groups, each dedicated to...(PRWeb February 04, 2012)Read the full story at http://www.... <p><a href="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/0/da"><img src="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/1/da"><img src="http://feedads.g.doubleclick.net/~a/z382Yymm9xFBFEhys4lkiQv20mc/1/di" border="0" ismap="true"></img></a></p><div class="feedflare"> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=eKJfeLMu3tc:IEzJieJ7hUE:yIl2AUoC8zA"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?d=yIl2AUoC8zA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=eKJfeLMu3tc:IEzJieJ7hUE:7Q72WNTAKBA"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?d=7Q72WNTAKBA" border="0"></img></a> <a href="http://feeds.feedburner.com/~ff/BiotechBlog?a=eKJfeLMu3tc:IEzJieJ7hUE:gIN9vFwOqvQ"><img src="http://feeds.feedburner.com/~ff/BiotechBlog?i=eKJfeLMu3tc:IEzJieJ7hUE:gIN9vFwOqvQ" border="0"></img></a> </div><img src="http://feeds.feedburner.com/~r/BiotechBlog/~4/eKJfeLMu3tc" height="1" width="1"/> http://www.biotechblog.com/2012/02/04/neuroscientists-join-max-planck-florida-institute-as-leaders-of-two/feed/ 0 http://www.biotechblog.com/2012/02/04/neuroscientists-join-max-planck-florida-institute-as-leaders-of-two/ Drug Patent Expirations for Jan 29 2012 http://feedproxy.google.com/~r/BiotechBlog/~3/7Gn7UkGnw8E/ http://www.biotechblog.com/2012/02/03/drug-patent-expirations-for-jan-29-2012/#comments Sat, 04 Feb 2012 01:25:08 +0000 DrugPatentWatch.com Drug Patent Expirations http://www.biotechblog.com/?guid=a14b88ca8596a7c401892296b74f7d19 If your reader cannot render the information below, go to http://www.DrugPatentWatch.com/innovation to see the latest expirations <table border="0" align="center"><TR><TD><a target="_new" href="http://www.drugpatentwatch.com/reports/orange-book-archives.html"><img border="0" src="http://www.drugpatentwatch.com/reports/img/banners/fda-orange-book-archives.gif" alt="FDA Orange Book archives from 2005 to present"></a><!--/td&#62;</tr><TR>&#60;TD align=right--><BR><a href="http://www.drugpatentwatch.com/newsletter/ad.php"><B>ADVERTISE HERE</B></a>&#160;</td></tr></table></p><P align="center"><i>This newsletter is a free service of <a href="http://www.drugpatentwatch.com/amember/go.php?r=132&#38;i=l0">DrugPatentWatch</a></i><br /><B>DrugPatentWatch offers comprehensive details on FDA approved drugs, developers, and their patents</B><BR /><table border="0" width="560" align="center"><TR><TD><div><b><b></b><b></b><b></b><b></b></b><div><h1>Simple flat-rate database subscription plans</h1><table><col><col><col><col><tr><td></td><td><a href="http://www.drugpatentwatch.com/ultimate">Ultimate Plan</a></td><td><a href="http://www.drugpatentwatch.com/premium">Premium Plan</a></td><td><a href="http://www.drugpatentwatch.com/basic">Basic Plan</a></td></tr><tr><td>One year</td><td>$1,895 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=1"><img src='http://www.DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><td>$1,695 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=3"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><td>$975 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=5"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></TD></a></tr><tr><td>One month</td><td>$475 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=2"><img src='http://www.DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><td>$375 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=4"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><TD>$275 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=6"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></td></a></tr><tr><td>48 hours</td><td></td><td>$95 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=37"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></a></td><TD>$75 <a href="http://www.drugpatentwatch.com/amember/signup.php?price_group=36"><img src='http://DrugPatentWatch.com/img/subscribe.gif' alt='Subscribe'></td></a></tr><TR><TD colspan="4"><a href="http://www.drugpatentwatch.com/comparison.php">Plan comparison</a>&#160;&#160;&#160;&#160;<a href="http://www.drugpatentwatch.com/index.php?tourId=Tour&#38;skinId=safari">Site tour</a>&#160;&#160;&#160;&#160;<a href="http://www.drugpatentwatch.com/contact.php">Contact</a></td></tr></table></div><b><b></b><b></b><b></b><b></b></b></div><BR /></tr></tr></table><table border="0" width="710" align="center"><TR><TD><div> <b> <b></b> <b></b> <b></b> <b></b></b><div><h1>Drug Patent Expirations for Jan 29 2012</h1><table width='100%' border="0"><thead><tr><th>Tradename</th><th>Applicant</th><th>Generic Name</th><th>Patent Number</th><th> Patent Expiration</th></tr></thead><tbody><tr><td>TASMAR</td><td>Valeant Pharm Intl</td><td>tolcapone</td><td>5,236,952</td><td>Jan 29, 2012</td></tr><TR><TD colspan="10"><p>*Drugs may be covered by multiple patents or regulatory protections. See the <a href="http://www.drugpatentwatch.com/amember/go.php?r=132&#38;i=l0">DrugPatentWatch</a> database for complete details.</p></TD></tr></tbody></table></div> <b> <b></b> <b></b><b></b> <b></b></b></div><div align="center"><hr /><div><B>The above list does not discriminate between dominant and non-dominant patents. Drugs listed above may be protected by additional patents and other regulatory protections. See the <a href="http://www.drugpatentwatch.com/amember/go.php?r=132&#38;i=l0">DrugPatentWatch</a> database for complete details</b><BR><BR><B>DISCLAIMER:</B><BR />Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.<BR /><i>All trademarks and applicant names are the property of their respective owners or licensors.</i></div></div><div> <a href="http://feeds.feedburner.com/~f/Drugpatentwatch?a=k0IwB1UJ"><img src="http://feeds.feedburner.com/~f/Drugpatentwatch?d=41" border="0"></img></a> <a href="http://feeds.feedburner.com/~f/Drugpatentwatch?a=wqCu3CQS"><img src="http://feeds.feedburner.com/~f/Drugpatentwatch?i=wqCu3CQS" border="0"></img></a> <a href="http://feeds.feedburner.com/~f/Drugpatentwatch?a=QDyqwQpa"><img src="http://feeds.feedburner.com/~f/Drugpatentwatch?d=50" border="0"></img></a> </div> <p><a href="http://feedads.g.doubleclick.net/~a/WqXeOSPhzqdPv1NpAMzdArF-V1M/0/da"><img src="http://feedads.g.doubleclick.net/~a/WqXeOSPhzqdPv1NpAMzdArF-V1M/0/di" border="0" ismap="true"></img></a><br/> <a href="http://feedads.g.doubleclick.net/~a/WqXeOSPhzqdPv1NpAMzdArF-V1M/1/da"><img src="http://feedads.g.doubleclick.net/~a/WqXeOSPhzqdPv1NpAMzdArF-V1M/1/di" border="0" ismap="true"></img></a></p><img src="http://feeds.feedburner.com/~r/BiotechBlog/~4/7Gn7UkGnw8E" height="1" width="1"/> http://www.biotechblog.com/2012/02/03/drug-patent-expirations-for-jan-29-2012/feed/ 0 http://www.biotechblog.com/2012/02/03/drug-patent-expirations-for-jan-29-2012/